Dr.Martinez said:I did go to 2.4mg in the end, and the honest report is that it bought me less than the step before it and cost me two bad weeks.
I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.
Worth separating that from semaglutide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.
Dr.Martinez said:I did go to 2.4mg in the end, and the honest report is that it bought me less than the step before it and cost me two bad weeks.
True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.
Dr.Martinez said:I did go to 2.4mg in the end, and the honest report is that it bought me less than the step before it and cost me two bad weeks.
Saving this. It is the first explanation that did not require me to already understand it. Printing the relevant bit and taking it with me.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsAdding the clinical framing, because it changes how the question reads. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.
PharmD_Rodriguez said:The distinction that resolves most of these threads is between what is true on average and what is true for one person.
Mine went the same way, slower. I had assumed I was the exception until I read this.